Of note, Rb function is impaired in most, if not all, lung cancers, whether directly by mutations in the RB1 gene itself or indirectly by mutations in the CDKN2 locus coding for p16INK4a [41, 42], which result in Rb inactivation by hyperphosphorylation. The gene discussed is CDKN2A; the disease is lung carcinoma.